Absorbable Suture with Needle Maxon Polyglyconate P-13 3/8 Circle Precision Reverse Cutting Needle Size 4-0 Monofilament

The Maxon suture is designed for durable support during critical healing phases. It maintains approximately 75% of its initial strength after two weeks and 50% after four weeks, providing reliable tissue approximation.

Yes, this suture is specifically indicated for pediatric cardiovascular applications, among other soft tissue procedures. Its material profile is well-suited for tissues where growth is a factor.

The Maxon suture features a predictable absorption profile: it remains largely intact with minimal absorption until 60 days post-implant, and it achieves essentially complete absorption within six months.

The 3/8 circle precision reverse cutting needle (P-13) is engineered to provide smooth tissue penetration. By utilizing a reverse-cutting configuration, it helps to minimize tissue trauma and tearing during suturing procedures.

No. This suture is not indicated for ophthalmic surgery, microsurgery, neural tissues, or adult cardiovascular tissue. It is strictly intended for general soft tissue approximation and ligation.

This is a synthetic monofilament suture crafted from polyglyconate, which is a copolymer of glycolic acid and trimethylene carbonate. This material allows for smooth passage through tissues during application.

No, this specific suture model is uncoated. Its design relies on the inherent properties of the monofilament polyglyconate to ensure smooth passage through tissue.

This suture is a 4-0 size and is clear in color, providing a minimalist and functional profile for standard surgical procedures.

This suture should be handled in accordance with standard clinical protocols for synthetic, absorbable, monofilament sutures to ensure optimal performance and safety.

Yes, this product is required to be reported under California Proposition 65. Please ensure your facility’s compliance protocols account for this requirement.